Xiaflex collagenase clostridium histolyticum regulatory update

EMEA accepted for filing an MAA from Pfizer Inc. (NYSE:PFE, New York, N.Y.) for Xiaflex collagenase clostridium histolyticum to treat Dupuytren's contracture, a condition that affects the joints in t...